Directory
>
Frederick Porter
Frederick Porter
Chief Technical Officer | Taysha Gene Therapies
Raleigh, North Carolina, United States
Frederick Porter
Summary
Frederick Porter is a seasoned biotechnology professional with extensive experience in scientific research and program management. As the Chief Technical Officer at Taysha Gene Therapies, he specializes in the technical development and manufacturing of biologics and vaccines. Frederick has a proven track record of advancing novel candidates from discovery to clinical trials, showcasing his expertise in viral vectors and recombinant proteins. He has held leadership roles across various organizations, including GSK and Novartis, where he led teams in drug substance development and vaccine manufacturing. With a PhD in Biochemistry from the University of Wisconsin-Madison, he combines scientific knowledge with strategic insight to drive innovation in the biopharmaceutical industry. Frederick is passionate about mentoring professionals in the field and is committed to advancing healthcare through biotechnological advancements.
Frederick Porter
Work Experience
Chief Technical Officer at
Taysha Gene Therapies
August 2020 - Present
Senior Vice President Technical Development and Manufacturing at
Bridgebio Services Inc.
March 2018 - August 2020
Sr. Director Product Development at
Duke University Medical Center
June 2016 - March 2018
Head, Drug Substance R&D at
GSK
September 2015 - June 2016
Head, Early and Exploratory Development Franchise (ad interim) at
GSK
September 2014 - September 2015
Department Head, US Analytical Development at
GSK
January 2015 - September 2015
Department Head, US Drug Substance (Viral Vaccines) at
Novartis
December 2012 - December 2014
Associate Director, Drug Substance Development at
Novartis
January 2012 - December 2012
Franchise Head --Viral Advanced Programs at
Novartis
April 2010 - February 2012
Principal Scientist at
Novartis
May 2009 - July 2011
Post-doctoral Research Associate at
University of Wisconsin-Madison
July 2008 - May 2009
Senior Research Associate at
Syntonix Pharmaceuticals
January 2002 - January 2003
Frederick Porter
Education
Frequently Asked Questions about Frederick Porter
What is Frederick Porter email address?
Frederick Porter's primary email address is *******@tayshagtx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Frederick Porter work for?
Frederick Porter is a Chief Technical Officer at Taysha Gene Therapies, a company specializing in Offices of health practitioner.
Where Frederick Porter graduated from?
Frederick Porter holds a degree in Biochemistry from University of Wisconsin-Madison.
How can I directly contact Frederick Porter?
To contact Frederick Porter directly, you can use the email address *******@tayshagtx.com. Complete contact information is available upon registration with Muraena.
Who is Frederick Porter?
Frederick Porter is a seasoned biotechnology professional with extensive experience in scientific research and program management. As the Chief Technical Officer at Taysha Gene Therapies, he specializes in the technical development and manufacturing of biologics and vaccines. Frederick has a proven track record of advancing novel candidates from discovery to clinical trials, showcasing his expertise in viral vectors and recombinant proteins. He has held leadership roles across various organizations, including GSK and Novartis, where he led teams in drug substance development and vaccine manufacturing. With a PhD in Biochemistry from the University of Wisconsin-Madison, he combines scientific knowledge with strategic insight to drive innovation in the biopharmaceutical industry. Frederick is passionate about mentoring professionals in the field and is committed to advancing healthcare through biotechnological advancements.
Frederick`s contact details
*******@tayshagtx.com
****************@novartis.com
****************@gsk.com
Colleagues
Director, Business Development & R&D Chief of Staff
President
Medical Affairs
Executive Director, Quality
Chief Executive Officer
Chief Financial Officer
Executive Director, Head of Patient Advocacy
Head of Market Access and Trade
Chief Patient and External Affairs Officer
Chief Patient Officer and Head of Government Affairs